Dom has found cheaper financing for the loan they took out to buy Track (7.5% vs current 12.5% iirc)
Part of the new financing deal gives the financers the option to take the repayments as shares instead of cash, though they will cop a 30% premium to current sp if they do so.
Dom can't just dilute shares willy nilly, he needs shareholder approval, hence the call for the egm.
They're also giving Hans a big chunk of shares for performance, unrelated to the refinancing deal. Not sure what that is all about and since they've been cagey on the recent performance of Track it's very hard to judge if it's warranted. If it's Sp performance we're going by, then all senior management deserve to take a hair cut imo, but who knows, maybe Hans has been smashing it... In which case Dom needs to make a better case.
If you're thinking of buying Cm8 shares please take the time to go through the announcements, or if it's a little bit too technical I'd recommend getting professional advice before taking the plunge.
- Forums
- ASX - By Stock
- UNT
- Ann: Notice of Extraordinary General Meeting/Proxy Form-CM8.AX
Ann: Notice of Extraordinary General Meeting/Proxy Form-CM8.AX, page-4
-
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNT (ASX) to my watchlist
|
|||||
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $19.57M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.5¢ | $3.248K | 203.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1172886 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 372999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1172886 | 0.015 |
9 | 3335044 | 0.014 |
12 | 2967718 | 0.013 |
11 | 4537249 | 0.012 |
13 | 2657594 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 372999 | 2 |
0.017 | 1392141 | 7 |
0.018 | 247679 | 3 |
0.019 | 1853336 | 5 |
0.020 | 1008805 | 6 |
Last trade - 10.50am 16/07/2024 (20 minute delay) ? |
Featured News
UNT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online